Keros Therapeutics's market cap is currently $651.88M. The company's EPS TTM is $-0.76; its P/E ratio is 51.23; Keros Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
